Prelude Therapeutics
PRLD
PRLD
46 hedge funds and large institutions have $39.1M invested in Prelude Therapeutics in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 22
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$901K | |
| 2 | +$60.4K | |
| 3 | +$25.9K | |
| 4 |
SC
Shay Capital
New York
|
+$25.1K |
| 5 |
HF
HRT Financial
New York
|
+$16.9K |
Top Sellers
| 1 | -$171K | |
| 2 | -$168K | |
| 3 | -$100K | |
| 4 |
Goldman Sachs
New York
|
-$70K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$65.4K |
